Streetbeat News

Products Services

PCSA

Processa Pharmaceuticals announced positive results from its Phase 1b trial of a next-generation capecitabine for Stage III/IV GI cancer. The trial established the maximum tolerated dose and recommended Phase 2 dose range, with 66.7% of patients achieving progression-free survival ranging from 5 to 11 months.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:21 pm

HYMTF

TSLA

South Korean automakers Hyundai and Kia have achieved a record-high 11.2% share of the U.S. electric vehicle (EV) market in the first five months of 2024, up from 6.8% in 2023. Despite this growth, they still trail Tesla, which leads the market by 40.5 percentage points.

Portfolio Pulse from Anan Ashraf

June 11, 2024 | 12:20 pm

NTAP

NetApp (NASDAQ:NTAP) has appointed Mike Sakalas as Vice President of U.S. Enterprise Sales to drive growth and enhance customer success. Sakalas will report to Riccardo Di Blasio, Senior Vice President of North America Sales, and will focus on developing and executing NetApp's enterprise business strategy in the U.S.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:20 pm

MOLN

Molecular Partners shares are trading higher following the announcement of their lead Raido-DARPin therapy candidate MP0712, which targets DLL3.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:20 pm

CRL

Charles River Laboratories International, Inc. (NYSE:CRL) has been awarded a $1.3 million grant from the Foundation for Chemistry Research & Initiatives to develop an in vitro alternative to inhalation toxicology studies. The project is a collaboration with MatTek Corporation and other partners, aiming to reduce reliance on traditional animal research methods.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:19 pm

TPET

Trio Petroleum Corp shares are trading higher after the company completed its first two exploratory wells.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:18 pm

OSPN

OneSpan Inc. (NASDAQ:OSPN) has launched the OneSpan Integration Platform, which allows organizations to integrate eSignatures into popular applications in a secure and cost-efficient manner.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:17 pm

COYA

Coya Therapeutics has published a Phase 1 study in Frontiers in Neurology showing promising results for its combination therapy of CTLA4-Ig and Interleukin-2 in treating ALS. The study demonstrated halting of disease progression and reduction in inflammation and oxidative stress over 24 weeks.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:16 pm

TPET

Trio Petroleum Corp (NYSE American: TPET) has successfully completed its first two exploratory wells in Uintah County, Utah. The HSO 8-4 well discovered over 100 feet of oil-bearing pay zone in the Rimrock Sandstone, while the HSO 2-4 well discovered over 120 feet in the Rimrock Sandstone and 69 feet in the Asphalt Ridge Sandstone.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:15 pm

META

Meta Platforms Inc. (NASDAQ:META) has updated its data use policies to include publicly shared content from European users on Instagram and Facebook for AI model training. This move has sparked multiple complaints from the digital rights group Noyb, which argues that these practices violate EU law. Despite these challenges, Meta's stock has surged 40% year-to-date and is nearing its all-time high.

Portfolio Pulse from Zaheer Anwari

June 11, 2024 | 12:14 pm